SP Industries Acquires Stability Environments
SP Industries (SP) has acquired privately held Stability Environments, a global provider of walk-in environmental rooms, glassware dryers, chambers and accessory products.
“Stability Environments has a well-earned reputation for producing high quality, often customized equipment and chambers supported by a knowledgeable manufacturing team” stated SP Industries CEO Bill Downs.
“Their product portfolio serves a diverse range of end user market segments including pharmaceutical, scientific, industrial and healthcare and is complementary to the current SP Scientific portfolio of concentrators, freeze dryers and thermal equipment. The SP Scientific family of brands is widely used in these markets, making Stability Environments an even more attractive tuck-in acquisition and excellent opportunity to continue to build on our success and bring increased value to our customers.”
Downs continued by saying: “We have moved all Stability Environments manufacturing from Glenside, PA to our Warminster, PA facility. Key manufacturing, engineering and service personnel have joined the SP team and Jay Silverman who had served as President of Stability Environments has been retained as a consultant assuring continuity in operations and quality."
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.